{"id":"W2151669647","doi":"10.2337/dc08-s258","title":"Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients","year":2008,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"Fonds Wetenschappelijk Onderzoek; GlaxoSmithKline; Vlaamse regering; Pfizer; AstraZeneca; Eli Lilly and Company; Pfizer Canada; Novo Nordisk; Sanofi; Abbott Laboratories","keywords":"Rimonabant; Medicine; Overweight; Type 2 diabetes; Dyslipidemia; Internal medicine; Population; Diabetes mellitus; Placebo; Metformin; Body mass index; Weight loss; Obesity; Endocrinology; Antagonist; Environmental health; Cannabinoid receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001016453,0.0001312016,0.0004930311,0.0002142583,0.00004667007,0.000002602475,0.00006335813,0.00006854464,0.000009201389],"category_scores_gemma":[0.0003226846,0.0001026183,0.0001471522,0.0002229283,0.0001191548,0.00003507599,0.00006534236,0.0001086033,4.785305e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006660416,"about_ca_system_score_gemma":0.00007918736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002844878,"about_ca_topic_score_gemma":0.000026429,"domain_scores_codex":[0.9988263,0.00002407558,0.0003282359,0.00021986,0.0003189787,0.0002825691],"domain_scores_gemma":[0.9991743,0.00005298161,0.0001069256,0.0002342256,0.0003167581,0.0001147854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002264907,0.0002266258,0.9720308,0.0005133656,0.00006883608,8.056896e-7,0.001759852,0.000009027835,0.008406595,0.000002441261,0.0003253145,0.01642982],"study_design_scores_gemma":[0.005849177,0.0008697411,0.9185842,0.00007129872,0.00004964632,8.651016e-8,0.0006352196,0.00005500351,0.0714149,0.000003615535,0.002378262,0.00008883666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966258,0.001208563,0.00000149278,0.00002361803,0.00006069858,0.001141358,0.0008706531,0.000006957069,0.00006088812],"genre_scores_gemma":[0.9993058,0.0003321528,0.00003812315,0.00001170472,0.00002742688,0.00006127144,0.0001583858,0.00001947304,0.00004561337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06300831,"threshold_uncertainty_score":0.4184651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01037209073205895,"score_gpt":0.2510864057302986,"score_spread":0.2407143149982396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}